Semaglutide 14 MG [Rybelsus]

DRUG3 trials

Sponsors

Rigshospitalet, Denmark, National Institute of Cardiology, Warsaw, Poland, University Medical Center Groningen

Conditions

Chronic Kidney DiseaseCoronary Artery DiseaseDiabetesHyperglycemiaPreDiabetesRenal Transplant Complication Primary Non-Function

Phase 2

Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide

CompletedNCT07819227

University Medical Center GroningenChronic Kidney Disease

Start: 2025-02-11End: 2026-08-31Updated: 2026-09-14

Phase 4

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation

RecruitingNCT05702931

Rigshospitalet, DenmarkDiabetes, Hyperglycemia, Renal Transplant Complication Primary Non-Function

Start: 2024-09-19End: 2027-12-31Target: 104Updated: 2025-12-29

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes

RecruitingNCT07254572

National Institute of Cardiology, Warsaw, PolandCoronary Artery Disease, PreDiabetes

Start: 2025-07-10End: 2029-08-01Target: 300Updated: 2025-11-28